• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视神经炎的复发率及复发时间

Incidence and timing of recurrence of optic neuritis.

作者信息

Park Kyung-Ah, Oh Sei Yeul, Min Ju-Hong, Kim Byoung Joon

机构信息

Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Ilwon-dong, Kangnam-gu, Seoul, Republic of Korea.

Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

出版信息

Graefes Arch Clin Exp Ophthalmol. 2019 Mar;257(3):651-655. doi: 10.1007/s00417-018-04217-7. Epub 2019 Jan 5.

DOI:10.1007/s00417-018-04217-7
PMID:30612145
Abstract

PURPOSE

To describe the incidence and timing of recurrence in patients with optic neuritis (ON).

METHODS

Medical documents of adult patients with ON were retrospectively reviewed. The incidence and timing of recurrence of an ON episode were analyzed.

RESULTS

One hundred eleven patients with ON were included in this study. Their mean follow-up duration was 4.1 ± 3.1 years. Seven relapses occurred after intravenous methylprednisolone treatment. The estimated cumulative incidence of recurrence in either eye was 26% at 1 year, 33% at 3 years, 37% at 5 years, and 50% at 10 years after the first episode of ON. If there was no recurrence until 6 months after the first episode of ON, the next 5-year recurrence-free survival probability was 67%. If there was no recurrence until 1 year, the next 5-year survival probability was 72%. If there was no recurrence until 2 years, the next 5-year survival probability was 81%. Relapse within 1 month and the presence of neuromyelitis optica-immunoglobulin G were factors that increased the recurrence rate over time.

CONCLUSIONS

We evaluated the incidence and timing of the recurrence in patients with ON after the first episode. Lower probability of recurrence was observed in patients with longer recurrence-free follow-up period. However, monitoring for recurrence is needed even in patients with a single episode of ON due to the increasing tendency of the estimated cumulative incidence of recurrence over many years.

摘要

目的

描述视神经炎(ON)患者复发的发生率及时间。

方法

对成年ON患者的医疗文件进行回顾性分析。分析ON发作复发的发生率及时间。

结果

本研究纳入111例ON患者。他们的平均随访时间为4.1±3.1年。静脉注射甲泼尼龙治疗后发生7次复发。首次ON发作后1年,单眼复发的估计累积发生率为26%,3年为33%,5年为37%,10年为50%。如果在首次ON发作后6个月内未复发,接下来5年无复发存活概率为67%。如果在1年内未复发,接下来5年存活概率为72%。如果在2年内未复发,接下来5年存活概率为81%。1个月内复发以及存在视神经脊髓炎免疫球蛋白G是随时间增加复发率的因素。

结论

我们评估了首次发作后ON患者复发的发生率及时间。复发无随访期较长的患者复发概率较低。然而,由于多年来估计累积复发发生率呈上升趋势,即使是单次发作的ON患者也需要监测复发情况。

相似文献

1
Incidence and timing of recurrence of optic neuritis.视神经炎的复发率及复发时间
Graefes Arch Clin Exp Ophthalmol. 2019 Mar;257(3):651-655. doi: 10.1007/s00417-018-04217-7. Epub 2019 Jan 5.
2
Association of Optic Neuritis with Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis in Korea.韩国视神经炎与视神经脊髓炎谱系障碍及多发性硬化症的关联
Korean J Ophthalmol. 2019 Feb;33(1):82-90. doi: 10.3341/kjo.2018.0050.
3
Clinical presentation of optic neuritis with autoantibodies anti-myelin oligodendrocyte glycoprotein.伴有抗髓鞘少突胶质细胞糖蛋白自身抗体的视神经炎的临床表现
Eur J Ophthalmol. 2019 Mar;29(2):257-261. doi: 10.1177/1120672118784797. Epub 2018 Jul 4.
4
Incidence and Mimickers of Acute Idiopathic Optic Neuritis: Analysis of 291 Consecutive Patients from Southern Finland.急性特发性视神经炎的发病率及模仿者:来自芬兰南部的291例连续患者分析
Ophthalmic Epidemiol. 2018 Oct-Dec;25(5-6):386-391. doi: 10.1080/09286586.2018.1500614. Epub 2018 Jul 24.
5
Baseline features of idiopathic optic neuritis as determined by a multicenter treatment trial in Japan. Optic Neuritis Treatment Trial Multicenter Cooperative Research Group (ONMRG).日本一项多中心治疗试验所确定的特发性视神经炎的基线特征。视神经炎治疗试验多中心合作研究组(ONMRG)。
Jpn J Ophthalmol. 1999 Mar-Apr;43(2):127-32. doi: 10.1016/s0021-5155(98)00072-0.
6
Visual function 5 years after optic neuritis: experience of the Optic Neuritis Treatment Trial. The Optic Neuritis Study Group.视神经炎后5年的视觉功能:视神经炎治疗试验的经验。视神经炎研究组。
Arch Ophthalmol. 1997 Dec;115(12):1545-52.
7
The clinical characteristics of optic neuritis in Korean children.韩国儿童视神经炎的临床特征
Korean J Ophthalmol. 2011 Apr;25(2):116-20. doi: 10.3341/kjo.2011.25.2.116. Epub 2011 Mar 11.
8
Comparison of visual acuity and automated perimetry findings in patients with neuromyelitis optica or multiple sclerosis after single or multiple attacks of optic neuritis.视神经炎单或多次发作后,视神经脊髓炎与多发性硬化患者的视力和自动视野检查结果比较。
J Neuroophthalmol. 2012 Jun;32(2):102-6. doi: 10.1097/WNO.0b013e31823a9ebc.
9
Population-based Incidence of Pediatric and Adult Optic Neuritis and the Risk of Multiple Sclerosis.基于人群的儿童和成人视神经炎发病率与多发性硬化症的风险。
Ophthalmology. 2020 Mar;127(3):417-425. doi: 10.1016/j.ophtha.2019.09.032. Epub 2019 Sep 27.
10
Paediatric optic neuritis: factors leading to unfavourable outcome and relapses.小儿视神经炎:导致不良结局和复发的因素。
Br J Ophthalmol. 2018 Jun;102(6):808-813. doi: 10.1136/bjophthalmol-2016-309978. Epub 2017 Sep 13.

引用本文的文献

1
A tale of two discs- normal to blurry, and the diagnostic dilemma! How to proceed?两张椎间盘的故事——从正常到模糊,以及诊断困境!如何应对?
Indian J Ophthalmol. 2024 Apr 1;72(4):471-472. doi: 10.4103/IJO.IJO_1521_23. Epub 2024 Mar 28.

本文引用的文献

1
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.视神经脊髓炎谱系障碍国际共识诊断标准
Neurology. 2015 Jul 14;85(2):177-89. doi: 10.1212/WNL.0000000000001729. Epub 2015 Jun 19.
2
Aquaporin-4 antibody negative recurrent isolated optic neuritis: clinical evidence for disease heterogeneity.水通道蛋白-4 抗体阴性复发性孤立性视神经炎:疾病异质性的临床证据。
J Neurol Sci. 2013 Aug 15;331(1-2):72-5. doi: 10.1016/j.jns.2013.05.012. Epub 2013 Jun 2.
3
Frequency and clinical patterns of multiple sclerosis in Arab countries: a systematic review.
阿拉伯国家多发性硬化症的发病率及临床模式:一项系统评价
J Neurol Sci. 2009 Mar 15;278(1-2):1-4. doi: 10.1016/j.jns.2008.12.001. Epub 2009 Jan 9.
4
Revised diagnostic criteria for neuromyelitis optica.视神经脊髓炎修订诊断标准。
Neurology. 2006 May 23;66(10):1485-9. doi: 10.1212/01.wnl.0000216139.44259.74.
5
Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria".多发性硬化症的诊断标准:对“麦克唐纳标准”的2005年修订版。
Ann Neurol. 2005 Dec;58(6):840-6. doi: 10.1002/ana.20703.
6
Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial.视神经炎后10多年的视觉功能:视神经炎治疗试验的经验
Am J Ophthalmol. 2004 Jan;137(1):77-83. doi: 10.1016/s0002-9394(03)00862-6.
7
Multiple sclerosis in the Japanese population.日本人群中的多发性硬化症。
Lancet Neurol. 2003 Feb;2(2):117-27. doi: 10.1016/s1474-4422(03)00308-9.
8
Optic neuromyelitis syndrome in Brazilian patients.巴西患者的视神经脊髓炎谱系障碍
J Neurol Neurosurg Psychiatry. 2002 Oct;73(4):429-35. doi: 10.1136/jnnp.73.4.429.
9
Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.多发性硬化症推荐诊断标准:国际多发性硬化症诊断小组指南
Ann Neurol. 2001 Jul;50(1):121-7. doi: 10.1002/ana.1032.
10
MS and neuromyelitis optica in Martinique (French West Indies).
Neurology. 2001 Feb 27;56(4):507-14. doi: 10.1212/wnl.56.4.507.